Risk	risk	O	O	O	O
factors	factors	O	O	O	O
of	of	O	O	O	O
sensorineural	sensorineural	O	DISEASE	OTHERS	I
hearing	hearing	O	DISEASE	OTHERS	I
loss	loss	O	DISEASE	OTHERS	I
in	in	O	O	O	O
preterm	preterm	O	O	OTHERS	I
infants	infants	O	O	OTHERS	I
.	.	O	O	O	O

Among	among	O	O	O	O
547	547	O	O	O	O
preterm	preterm	O	O	OTHERS	I
infants	infants	O	O	OTHERS	I
of	of	O	O	O	O
<	<	O	O	O	O
or	or	O	O	O	O
=	=	O	O	O	O
34	34	O	O	O	O
weeks	weeks	O	O	O	O
gestation	gestation	O	O	O	O
born	born	O	O	O	O
between	between	O	O	O	O
1987	1987	O	O	O	O
and	and	O	O	O	O
1991	1991	O	O	O	O
,	,	O	O	O	O
8	8	O	O	O	O
children	children	O	O	O	O
(	(	O	O	O	O
1.46	1.46	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
developed	developed	O	O	O	O
severe	severe	O	O	O	O
progressive	progressive	O	O	O	O
and	and	O	O	O	O
bilateral	bilateral	O	O	O	O
sensorineural	sensorineural	O	DISEASE	OTHERS	I
hearing	hearing	O	DISEASE	OTHERS	I
loss	loss	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Perinatal	perinatal	O	O	O	O
risk	risk	O	O	O	O
factors	factors	O	O	O	O
of	of	O	O	O	O
infants	infants	O	O	O	O
with	with	O	O	O	O
hearing	hearing	O	DISEASE	OTHERS	I
loss	loss	O	DISEASE	OTHERS	I
were	were	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
those	those	O	O	O	O
of	of	O	O	O	O
two	two	O	O	O	O
control	control	O	O	O	O
groups	groups	O	O	O	O
matched	matched	O	O	O	O
for	for	O	O	O	O
gestation	gestation	O	O	O	O
and	and	O	O	O	O
birth	birth	O	DISEASE	OTHERS	I
weight	weight	O	DISEASE	OTHERS	I
and	and	O	O	O	O
for	for	O	O	O	O
perinatal	perinatal	O	O	O	O
complications	complications	O	O	O	O
.	.	O	O	O	O

Our	our	O	O	O	O
observations	observations	O	O	O	O
demonstrated	demonstrated	O	O	O	O
an	an	O	O	O	O
association	association	O	O	O	O
of	of	O	O	O	O
hearing	hearing	O	DISEASE	OTHERS	I
loss	loss	O	DISEASE	OTHERS	I
with	with	O	O	O	O
a	a	O	O	O	O
higher	higher	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
perinatal	perinatal	O	O	O	O
complications	complications	O	O	O	O
.	.	O	O	O	O

Ototoxicity	ototoxicity	O	DISEASE	OTHERS	I
appeared	appeared	O	O	O	O
closely	closely	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
prolonged	prolonged	O	O	O	O
administration	administration	O	O	O	O
and	and	O	O	O	O
higher	higher	O	O	O	O
total	total	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
ototoxic	ototoxic	O	O	OTHERS	I
drugs	drugs	O	O	O	O
,	,	O	O	O	O
particularly	particularly	O	O	O	O
aminoglycosides	aminoglycosides	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
furosemide	furosemide	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Finally	finally	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
strongly	strongly	O	O	O	O
recommend	recommend	O	O	O	O
to	to	O	O	O	O
prospectively	prospectively	O	O	O	O
and	and	O	O	O	O
regularly	regularly	O	O	O	O
perform	perform	O	O	O	O
audiologic	audiologic	O	O	O	O
assessment	assessment	O	O	O	O
in	in	O	O	O	O
sick	sick	O	O	O	O
preterm	preterm	O	O	O	O
children	children	O	O	O	O
as	as	O	O	O	O
hearing	hearing	O	DISEASE	OTHERS	I
loss	loss	O	DISEASE	OTHERS	I
is	is	O	O	O	O
of	of	O	O	O	O
delayed	delayed	O	O	O	O
onset	onset	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
most	most	O	O	O	O
cases	cases	O	O	O	O
bilateral	bilateral	O	O	O	O
and	and	O	O	O	O
severe	severe	O	O	O	O
.	.	O	O	O	O

